BioNTech SE: xbrl:CashFlowsFromUsedInFinancingActivities
| Value | {"unit": "EUR", "value": -45900000} |
|---|---|
| Period | 2024-01-01 – 2024-12-31 |
| Status | current |
| Entity | BioNTech SE |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/edbd3ade-f288-469c-8f5a-9baeb08148ac
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001776985-25-000013Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/edbd3ade-f288-469c-8f5a-9baeb08148ac
History
- no predecessors — first report